Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.41 |
| ▸ | PTGER1 | P34995 | 15/20 | 0.41 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.38 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.38 |
| ▸ | TEAD2 | Q15562 | 1/20 | 0.38 |
| ▸ | TEAD3 | Q99594 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15076257 | 0.89 | PTGER1 (0.44) | SLC22A12PTGER1 | |
| SCHEMBL15076261 | 0.86 | SLC22A12 (0.43) | SLC22A12PTGER1 | |
| SCHEMBL15076186 | 0.82 | PTGER1 (0.43) | SLC22A12PTGER1TEAD1TEAD4TEAD2 | |
| SCHEMBL15076249 | 0.81 | PTGER1 (0.41) | PTGER1ALDH1A1MAPTPKMTSHR | |
| SCHEMBL15076238 | 0.79 | SLC22A12 (0.43) | SLC22A12PTGER1 | |
| SCHEMBL15076210 | 0.78 | PTGER1 (0.39) | PTGER1ALDH1A1MAPTPKMTSHR | |
| SCHEMBL15076242 | 0.77 | RORC (0.45) | SLC22A12PTGER1ALDH1A1MAPTPKM | |
| SCHEMBL15076266 | 0.75 | PTGER1 (0.57) | PTGER1 | |
| SCHEMBL15053916 | 0.75 | PTGER1 (0.46) | SLC22A12PTGER1 | |
| SCHEMBL20628878 | 0.74 | PTGER1 (0.40) | PTGER1ALDH1A1MAPTPKMTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3424904-A1 | COMPOUNDS ACTING AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE | Allergan, Inc. (US) | 2019-01-09 | — | — | EP | disclosed |